Rumor has it that a large pharma company is considering offering $580mm in cash for PROLOR. IMHO, if this is true, management will not accept it as they would prefer to participate in the future growth by receiving shares.
We own 2% of PBTH and will vote no on this deal. Shame on PBTH management. They know this company is worth at least $12 a share. Maybe that is why they did not wait until the beginning of phase lll on the GH product. We should do something about this. They are just stealing this company from us.
A friend of mine told me that the analyst at Summer have not spoken to the company for a long time. IMHO he just came out with a sell opinion to generated commissions now that business is so bad for these brokerage houses.
Presented at GTC's 5th Diabetes Drug Discovery and Development Conference on April 19, 2012 in Boston, MA:
I do not see any merit on your complain, they filled with the SEC and that is all they are required to do.